Literature DB >> 15660455

Animal models of arthritis. What have we learned?

Wim B van den Berg1.   

Abstract

Animal models of arthritis can be used to understand elements of the arthritic process in patients. Recent therapeutic approaches in patients with rheumatoid arthritis (RA) with biologics are based on initial findings in murine models of experimental arthritis, although final proof of concept must come from clinical studies. Animal models are powerful tools for studying pathologic changes in articular cartilage and bone in great detail, and can be used to evaluate mechanisms of erosive processes. Although in general more inflammation drives more destruction, the uncoupling of inflammation and erosion can be seen as well, and different mediators are involved in these processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15660455

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  10 in total

Review 1.  Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Authors:  Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

Review 2.  The role of the lymphatic system in inflammatory-erosive arthritis.

Authors:  Echoe M Bouta; Jie Li; Yawen Ju; Edward B Brown; Christopher T Ritchlin; Lianping Xing; Edward M Schwarz
Journal:  Semin Cell Dev Biol       Date:  2015-01-15       Impact factor: 7.727

3.  Measuring intranodal pressure and lymph viscosity to elucidate mechanisms of arthritic flare and therapeutic outcomes.

Authors:  Echoe M Bouta; Ronald W Wood; Seth W Perry; Edward B Brown; Christopher T Ritchlin; Lianping Xing; Edward M Schwarz
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2007-12

Review 5.  The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self.

Authors:  Dennis McGonagle; Sinisa Savic; Michael F McDermott
Journal:  Semin Immunopathol       Date:  2007-09-06       Impact factor: 11.759

6.  Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis.

Authors:  Rong Li; Xiufen Zheng; Igor Popov; Xusheng Zhang; Hongmei Wang; Motohiko Suzuki; Rosalia De Necochea-Campion; Peter W French; Di Chen; Leo Siu; David Koos; Robert D Inman; Wei-Ping Min
Journal:  J Transl Med       Date:  2012-01-31       Impact factor: 5.531

7.  Comparative Evaluation of 68Ga-Citrate PET/CT and 18F-FDG PET/CT in the Diagnosis of Type II Collagen-Induced Arthritis in Rats.

Authors:  Zi Wang; Liang Cai; Tingting Xu; Dan Tang; Lin Liu; Yue Chen
Journal:  Contrast Media Mol Imaging       Date:  2019-03-19       Impact factor: 3.161

Review 8.  Cells of the synovium in rheumatoid arthritis. Chondrocytes.

Authors:  Miguel Otero; Mary B Goldring
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Repeated Electroacupuncture Persistently Elevates Adenosine and Ameliorates Collagen-Induced Arthritis in Rats.

Authors:  Tian-Shen Ye; Zhong-Heng Du; Zhi-Hui Li; Wen-Xia Xie; Ka-Te Huang; Yong Chen; Zhou-Yang Chen; Huan Hu; Jun-Lu Wang; Jian-Qiao Fang
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-31       Impact factor: 2.629

10.  Time-dependent proteomic and genomic alterations in Toll-like receptor-4-activated human chondrocytes: increased expression of lamin A/C and annexins.

Authors:  Seung Hee Ha; Hyoung Kyu Kim; Nguyen Thi Tuyet Anh; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2017-08-22       Impact factor: 2.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.